Aditi Dutt

Array ( [id] => 13425077 [patent_doc_number] => 20180264081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-09-20 [patent_title] => THERAPEUTIC PROTEIN FORMULATIONS [patent_app_type] => utility [patent_app_number] => 15/544482 [patent_app_country] => US [patent_app_date] => 2016-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6649 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15544482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10749757 [patent_doc_number] => 20160095908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-07 [patent_title] => 'Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies' [patent_app_type] => utility [patent_app_number] => 14/966759 [patent_app_country] => US [patent_app_date] => 2015-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16725 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14966759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11706277 [patent_doc_number] => 20170174776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-22 [patent_title] => 'METHOD AND CONSTRUCTS FOR THE pH DEPENDENT PASSAGE OF THE BLOOD-BRAIN-BARRIER' [patent_app_type] => utility [patent_app_number] => 14/956268 [patent_app_country] => US [patent_app_date] => 2015-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17233 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14956268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12051444 [patent_doc_number] => 20170327789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'Modulation of Dopamine Receptor to Promote Neural Cell Differentiation' [patent_app_type] => utility [patent_app_number] => 15/526105 [patent_app_country] => US [patent_app_date] => 2015-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4131 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15526105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10820477 [patent_doc_number] => 20160166641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'METHOD OF TREATING PERIPHERAL NERVE DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/939154 [patent_app_country] => US [patent_app_date] => 2015-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5714 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14939154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17635172 [patent_doc_number] => 11345888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-31 [patent_title] => Method and pharmaceutical composition for continuously maintaining growth of a motor neuron progenitor cell [patent_app_type] => utility [patent_app_number] => 14/929017 [patent_app_country] => US [patent_app_date] => 2015-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 4232 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14929017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13024473 [patent_doc_number] => 10034848 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-31 [patent_title] => Increase of protein synthesis ameliorates synaptopathy-related neurological disorders [patent_app_type] => utility [patent_app_number] => 14/925007 [patent_app_country] => US [patent_app_date] => 2015-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7041 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14925007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13165507 [patent_doc_number] => 10098844 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-16 [patent_title] => Enzyme delivery systems and methods of preparation and use [patent_app_type] => utility [patent_app_number] => 14/921896 [patent_app_country] => US [patent_app_date] => 2015-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17235 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14921896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10769052 [patent_doc_number] => 20160115208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'USE OF AN IMMUNOMODULATORY PROTEIN FROM GANODERMA IN PROMOTING NEURITE OUTGROWTH' [patent_app_type] => utility [patent_app_number] => 14/918132 [patent_app_country] => US [patent_app_date] => 2015-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4804 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14918132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12058633 [patent_doc_number] => 20170334977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'Targeting Apolipoprotein E (APOE) in Neurologic Disease' [patent_app_type] => utility [patent_app_number] => 15/520039 [patent_app_country] => US [patent_app_date] => 2015-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 24170 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15520039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10755003 [patent_doc_number] => 20160101155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-14 [patent_title] => 'METHODS OF TREATING NEUROLOGICAL AUTOIMMUNE DISORDERS WITH CYCLOPHOSPHAMIDE' [patent_app_type] => utility [patent_app_number] => 14/884521 [patent_app_country] => US [patent_app_date] => 2015-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24803 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14884521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10736008 [patent_doc_number] => 20160082158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'CELLULAR TRANSPLANT SITE' [patent_app_type] => utility [patent_app_number] => 14/863541 [patent_app_country] => US [patent_app_date] => 2015-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11391 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14863541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10823749 [patent_doc_number] => 20160169914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'KINETICS BIOMARKERS FOR NEURODEGENERATION' [patent_app_type] => utility [patent_app_number] => 14/857745 [patent_app_country] => US [patent_app_date] => 2015-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29026 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14857745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11197243 [patent_doc_number] => 09427438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-30 [patent_title] => 'Compositions and methods for treating Alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 14/855338 [patent_app_country] => US [patent_app_date] => 2015-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11901 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14855338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11948264 [patent_doc_number] => 20170252415 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-09-07 [patent_title] => 'Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect' [patent_app_type] => utility [patent_app_number] => 14/852990 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8462 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14852990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11948264 [patent_doc_number] => 20170252415 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2017-09-07 [patent_title] => 'Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect' [patent_app_type] => utility [patent_app_number] => 14/852990 [patent_app_country] => US [patent_app_date] => 2015-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8462 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14852990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11979675 [patent_doc_number] => 20170283829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'SPRR1A AS A GENETIC TARGET FOR TREATING NEURODEGENERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 15/507569 [patent_app_country] => US [patent_app_date] => 2015-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13906 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12023928 [patent_doc_number] => 20170314027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION' [patent_app_type] => utility [patent_app_number] => 15/502113 [patent_app_country] => US [patent_app_date] => 2015-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23380 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10412678 [patent_doc_number] => 20150297688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect' [patent_app_type] => utility [patent_app_number] => 14/753917 [patent_app_country] => US [patent_app_date] => 2015-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8423 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14753917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11556151 [patent_doc_number] => 20170102397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-13 [patent_title] => 'METHOD FOR ENRICHING CNS-DERIVED EXOSOMES' [patent_app_type] => utility [patent_app_number] => 15/112461 [patent_app_country] => US [patent_app_date] => 2015-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4957 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15112461 [rel_patent_id] =>[rel_patent_doc_number] =>)